Shares of LiveRamp Holdings, Inc. (NYSE:RAMP – Get Free Report) have received a consensus rating of “Buy” from the four research firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $35.00.
A number of brokerages have issued reports on RAMP. Morgan Stanley boosted their price target on LiveRamp from $34.00 to $37.00 and gave the company an “overweight” rating in a report on Thursday, August 10th. Benchmark reissued a “buy” rating and issued a $37.00 price target on shares of LiveRamp in a report on Tuesday. TheStreet raised LiveRamp from a “d+” rating to a “c-” rating in a report on Wednesday, August 16th. Finally, StockNews.com began coverage on LiveRamp in a research note on Thursday, October 5th. They set a “strong-buy” rating for the company.
LiveRamp Stock Up 1.6 %
LiveRamp (NYSE:RAMP – Get Free Report) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. LiveRamp had a negative return on equity of 3.72% and a negative net margin of 15.30%. The company had revenue of $154.07 million during the quarter, compared to the consensus estimate of $147.00 million. Research analysts anticipate that LiveRamp will post 0.37 EPS for the current fiscal year.
Insider Activity at LiveRamp
In other LiveRamp news, CTO Mohsin Hussain sold 9,470 shares of the business’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $31.11, for a total transaction of $294,611.70. Following the sale, the chief technology officer now directly owns 116,864 shares in the company, valued at $3,635,639.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.93% of the company’s stock.
Hedge Funds Weigh In On LiveRamp
Several institutional investors have recently added to or reduced their stakes in RAMP. BlackRock Inc. raised its holdings in shares of LiveRamp by 0.8% in the 3rd quarter. BlackRock Inc. now owns 11,568,006 shares of the company’s stock worth $210,074,000 after purchasing an additional 92,629 shares during the period. Vanguard Group Inc. raised its holdings in shares of LiveRamp by 3.3% in the 3rd quarter. Vanguard Group Inc. now owns 7,226,457 shares of the company’s stock worth $131,232,000 after purchasing an additional 230,620 shares during the period. Schroder Investment Management Group raised its holdings in shares of LiveRamp by 6.6% in the 2nd quarter. Schroder Investment Management Group now owns 3,603,567 shares of the company’s stock worth $102,918,000 after purchasing an additional 224,464 shares during the period. Capital International Investors raised its holdings in shares of LiveRamp by 8.7% in the 1st quarter. Capital International Investors now owns 3,065,422 shares of the company’s stock worth $114,616,000 after purchasing an additional 244,405 shares during the period. Finally, Lazard Asset Management LLC raised its holdings in shares of LiveRamp by 13.9% in the 1st quarter. Lazard Asset Management LLC now owns 2,883,554 shares of the company’s stock worth $107,815,000 after purchasing an additional 351,876 shares during the period. 90.50% of the stock is currently owned by institutional investors and hedge funds.
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
- Five stocks we like better than LiveRamp
- Health Care Stocks Explained: Why You Might Want to Invest
- Investing in large cap stocks: Diving into big caps
- How to Invest in Energy
- Why you can make Vertex Pharmaceuticals a buy on any pullback
- When to Sell a Stock for Profit or Loss
- Occidental Petroleum: Another bounce from the buy zone
Receive News & Ratings for LiveRamp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiveRamp and related companies with MarketBeat.com's FREE daily email newsletter.